BRANDES INVESTMENT PARTNERS, LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$27,877,493
+0.5%
1,802,036
+2.1%
0.54%
-2.7%
Q2 2023$27,733,159
-7.4%
1,765,319
-2.9%
0.56%
-12.1%
Q1 2023$29,960,175
+1521.8%
1,817,972
+1435.2%
0.64%
+1123.1%
Q4 2022$1,847,352
-92.4%
118,420
-93.7%
0.05%
-91.8%
Q3 2022$24,267,000
-14.5%
1,871,043
-7.5%
0.64%
-8.4%
Q2 2022$28,396,000
-6.0%
2,022,547
-4.1%
0.69%
+7.1%
Q1 2022$30,213,000
+26.7%
2,109,846
+20.6%
0.65%
+24.4%
Q4 2021$23,850,000
-27.8%
1,749,763
-13.2%
0.52%
-27.5%
Q3 2021$33,019,000
-5.8%
2,015,824
-3.2%
0.72%
-8.0%
Q2 2021$35,044,000
+8.5%
2,082,235
+18.3%
0.78%
+1.8%
Q1 2021$32,311,000
+6.9%
1,760,848
+5.9%
0.76%
-1.8%
Q4 2020$30,235,000
+16.5%
1,663,081
+14.3%
0.78%
-13.2%
Q3 2020$25,958,000
-13.4%
1,455,039
-12.9%
0.90%
-1.6%
Q2 2020$29,958,000
+9.7%
1,670,809
-7.1%
0.91%
-4.5%
Q1 2020$27,298,000
-19.2%
1,798,239
+5.0%
0.96%
+18.8%
Q4 2019$33,804,000
+6.6%
1,713,349
-7.0%
0.80%
-2.0%
Q3 2019$31,704,000
+33.3%
1,843,235
+37.2%
0.82%
+54.7%
Q2 2019$23,778,000
-21.0%
1,343,416
-9.0%
0.53%
-24.2%
Q1 2019$30,087,000
+76.4%
1,477,015
+45.7%
0.70%
+61.1%
Q4 2018$17,053,0001,013,8820.43%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders